CANF short interest
Can-Fite BioPharma Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 55,612 |
|---|---|
| Change vs prior report | -3,767 (-6.3%) |
| Change over six months | +48.6% |
| Days to cover | 1.18 (sector: 3.78) |
| Average daily volume | 47,321 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
CANF short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 55,612 | -6.3% | 1.18 | 47,321 |
| 2026-09-15 | 59,379 | -4.0% | 1.00 | 2,140,558 |
| 2026-08-31 | 61,837 | +0.0% | 1.96 | 31,522 |
| 2026-08-14 | 61,815 | -6.5% | 1.66 | 37,194 |
| 2026-07-31 | 66,087 | -40.0% | 1.59 | 41,646 |
| 2026-07-15 | 110,193 | -65.7% | 1.00 | 6,157,256 |
| 2026-06-30 | 321,495 | +583.3% | 1.00 | 2,602,702 |
| 2026-06-15 | 47,052 | -30.6% | 1.48 | 31,756 |
| 2026-05-29 | 67,832 | -41.8% | 3.06 | 22,190 |
| 2026-05-15 | 116,564 | +397.8% | 1.00 | 192,517 |
| 2026-04-30 | 23,418 | +25.7% | 1.00 | 2,500,586 |
| 2026-04-15 | 18,629 | -50.2% | 1.00 | 27,664 |
| 2026-03-31 | 37,433 | -19.4% | 1.00 | 44,416 |
| 2026-03-13 | 46,458 | -45.8% | 1.00 | 4,061,460 |
| 2026-02-27 | 85,759 | -4.9% | 3.84 | 22,318 |
| 2026-02-13 | 90,169 | +19.3% | 1.15 | 78,742 |
| 2026-01-30 | 75,562 | +5.3% | 1.10 | 68,694 |
| 2026-01-15 | 71,744 | -98.2% | 1.00 | 374,813 |
| 2025-12-31 | 4,068,255 | +12128.7% | 1.00 | 18,366,769 |
| 2025-12-15 | 33,268 | -87.2% | 1.00 | 969,806 |
| 2025-11-28 | 260,501 | +373.4% | 1.00 | 42,571,276 |
| 2025-11-14 | 55,033 | +7.1% | 1.00 | 130,060 |
| 2025-10-31 | 51,399 | +6.5% | 1.00 | 175,673 |
| 2025-10-15 | 48,282 | -67.0% | 1.00 | 372,227 |
| 2025-09-30 | 146,532 | +43.0% | 1.02 | 144,083 |
import finzdata as yf
yf.Ticker("CANF").short_interest # every report since 2017
yf.Client().short_interest(["CANF"], start="2018-01-01")Healthcare short interest · CANF price history · Who owns CANF · All short interest